跳到正文

法规知识库 · EMA 集中审评

Leflunomide Zentiva (previously Leflunomide Winthrop)

leflunomide · EMEA/H/C/001129 · 已授权

获批上市许可

2010-01-08

欧委会决定日

2026-09-22

持有人 / 申请人

Zentiva k.s.

终止日期字段

无

从产品到官方文件

文件记录

8

官方索引 8

EPAR / 审评

6

assessment / overview 等

产品信息

2

PI / presentations

其他

0

RMP / PIP 等

ATC:L04AK01

治疗领域:Arthritis, Rheumatoid;Arthritis, Psoriatic

药理分类:immunosuppressants

修订号:24 · 最新影响 PI 的程序:VR/0000368533

适应症(原文):Leflunomide is indicated for the treatment of adult patients with: active rheumatoid arthritis as a 'disease-modifying antirheumatic drug' (DMARD); active psoriatic arthritis. Recent or concurrent treatment with hepatotoxic or haematotoxic DMARDs (e.g. methotrexate) may result in an increased risk of serious adverse reactions; therefore, the initiation of leflunomide treatment has to be carefully considered regarding these benefit / risk aspects. Moreover, switching from leflunomide to another DMARD without following the washout procedure may also increase the risk of serious adverse reactions even for a long time after the switching.

关键日期时间轴

来自 EMA medicines JSON 日期字段;缺失字段不展示,不补推结论。

  1. 2026-09-22 · 欧委会决定

  2. 2010-01-08 · 获批上市许可

说明书、EPAR 与其他文件

仅展示 EMA 官方 document_url;本站不下载或镜像 PDF。

EPAR / 审评资料 6产品信息 2其他 0

EPAR / 审评资料

  • Leflunomide Zentiva : EPAR - Procedural steps taken and scientific information after authorisation

    procedural-steps-after · 2026-09-22

    打开官方文件 ↗
  • Leflunomide Zentiva (previously Leflunomide Winthrop) : EPAR - Risk management plan

    rmp · 2026-09-22

    打开官方文件 ↗
  • Leflunomide Zentiva (previously Leflunomide Winthrop) : EPAR - Procedural steps taken and scientific information after authorisation (archive)

    procedural-steps-after · 2025-01-09

    打开官方文件 ↗
  • Leflunomide-H-C-PSUSA-00001837-202309 : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)

    scientific-conclusion · 2024-08-14 · EMA/352982/2024

    打开官方文件 ↗
  • Leflunomide Zentiva (previously Leflunomide Winthrop) : EPAR - Medicine overview

    overview · 2019-06-13

    打开官方文件 ↗
  • Leflunomide Winthrop : EPAR - Public assessment report

    assessment-report · 2010-01-22

    打开官方文件 ↗

产品信息

  • Leflunomide Zentiva : EPAR - Product information

    product-information · 2026-09-22

    打开官方文件 ↗
  • Leflunomide Zentiva (previously Leflunomide Winthrop) : EPAR - All Authorised presentations

    all-authorised-presentations · 2019-06-13

    打开官方文件 ↗

数据来自 EMA 官方 JSON;最终以 EMA / 欧委会文件为准。本页不自动给出安全或非安全结论。